CryoLife, Inc. Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	52
ISBN Number	not applicable
Product Code	GMD04767

Price

£490.00
approximately: $749 | €546

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a CryoLife, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook Cardiovascular Devices
3 Business Description
- 3.1 Business Overview
- 3.2 Major Products and Services
  - 3.2.1 Overview
4 History
5 Competitors
6 Key Employees
7 Key Employee Biographies
8 Company Statement
9 Locations And Subsidiaries
- 9.1 Head Office
10 Recent Developments
- 10.1 Strategy And Business Planning
  - 10.1.1 Jan 08, 2008: CryoLife Signs License Agreement With Trophic For Organ Transport Solution
- 10.2 Financial Announcements
  - 10.2.1 Jul 31, 2008: CryoLife Declares 2Q 2008 Results
  - 10.2.2 Apr 30, 2008: CryoLife Declares Q1 2008 Results
  - 10.2.3 Apr 14, 2008: CryoLife To Declare Q1 2008 Results
  - 10.2.4 Feb 21, 2008: CryoLife Reports Q4 2007 Results
  - 10.2.5 Nov 01, 2007: CryoLife Reports 3Q 2007 Results
  - 10.2.6 Oct 11, 2007: CryoLife Declares Preliminary Q3 2007 Results
  - 10.2.7 Jul 31, 2007: CryoLife Declares Q2 2007 Results
  - 10.2.8 May 01, 2007: CryoLife Declares Q1 2007 Results
  - 10.2.9 Mar 13, 2007: CryoLife Declares Preferred Dividend
  - 10.2.10 Jan 11, 2007: CryoLife Declares Preliminary Q4 2006 Results
- 10.3 Corporate Communications
  - 10.3.1 Aug 04, 2008: CryoLife Announces Senior Management Promotions
  - 10.3.2 May 01, 2008: CryoLife Elects New Board Member
  - 10.3.3 Apr 08, 2008: CryoLife Appoints Vice President, Medical Relations And Education
  - 10.3.4 Oct 30, 2007: CryoLife Announces Management Changes
  - 10.3.5 Sep 04, 2007: CryoLife Appoints VP, General Counsel
- 10.4 Product News
  - 10.4.1 Jul 01, 2008: Positive Midterm Results Reported For Pulmonary Human Heart Valve
  - 10.4.2 Jun 10, 2008: CryoLife, Inc. BioGlue Surgical Adhesive Receives European Approval For Use In Browlift Cosmetic And Reconstructive Plastic Surgery
  - 10.4.3 May 13, 2008: CryoLife Inc, Announces First Implant Of Combination Aortic-Mitral Allograft Heart Valve At The Cleveland Clinic
  - 10.4.4 Apr 24, 2008: CryoLife Conducts Surgeons Cardiac Allograft Symposium
  - 10.4.5 Mar 24, 2008: CryoLife Announces Implant Of First FDA-Cleared SynerGraft Processed Human Pulmonary Heart Valve
  - 10.4.6 Feb 07, 2008: CryoLife Receives FDA 510(k) Clearance For SynerGraft Processed Human Pulmonary Heart Valves
  - 10.4.7 Sep 17, 2007: CryoLife Signs Distribution Agreement For Inclusion Of BioGlue Surgical Adhesive In Hernia Repair Kit With Proxy Biomedical Surgical Meshes
  - 10.4.8 Jun 26, 2007: BioForm Medical Enrolls First Patient In Clinical Trial Of CryoLife's BioGlue Surgical Adhesive For Use In Cosmetic And Plastic Surgery
  - 10.4.9 Jun 14, 2007: CryoLife Awarded US Patent For BioFoam
  - 10.4.10 Apr 30, 2007: CryoLife's BioDisc Nucleus Pulposus Replacement To Be Featured At Two Medical Conferences In Berlin
  - 10.4.11 Jan 10, 2007: CryoLife Announces Agreement With Cleveland Clinic To Develop Innovative Heart Valve For High Risk Patients
- 10.5 Product Approvals
  - 10.5.1 Jun 10, 2008: CryoLife, Inc. BioGlue Surgical Adhesive Receives European Approval For Use In Browlift Cosmetic And Reconstructive Plastic Surgery
  - 10.5.2 Feb 07, 2008: CryoLife Receives FDA 510(k) Clearance For SynerGraft Processed Human Pulmonary Heart Valves
- 10.6 Clinical Trials
  - 10.6.1 Jul 01, 2008: Positive Midterm Results Reported For Pulmonary Human Heart Valve
  - 10.6.2 May 13, 2008: CryoLife Inc, Announces First Implant Of Combination Aortic-Mitral Allograft Heart Valve At The Cleveland Clinic
  - 10.6.3 Mar 24, 2008: CryoLife Announces Implant Of First FDA-Cleared SynerGraft Processed Human Pulmonary Heart Valve
  - 10.6.4 Jun 26, 2007: BioForm Medical Enrolls First Patient In Clinical Trial Of CryoLife's BioGlue Surgical Adhesive For Use In Cosmetic And Plastic Surgery
- 10.7 Other Significant Developments
  - 10.7.1 Dec 19, 2006: RTI, CryoLife Enter Into Exchange And Service Agreement
11 CryoLife, Inc. Pipeline Products
- 11.1 CryoLife, Inc. Product Pipeline Analysis
  - 11.1.1 CryoLife, Inc. Pipeline Products By Equipment Type
  - 11.1.2 CryoLife, Inc. Pipeline Products By Development Stage
  - 11.1.3 CryoLife, Inc. Pipeline Products By Therapy Area
  - 11.1.4 CryoLife, Inc. Pipeline Products By Clinical Trials
  - 11.1.5 CryoLife, Inc. Pipeline Products By News Summary
- 11.2 Biodisc
  - 11.2.1 Product Description
  - 11.2.2 Product Status
  - 11.2.3 Clinical Trials
  - 11.2.4 Product Milestone
- 11.3 CryoValve SG
  - 11.3.1 Product Description
  - 11.3.2 Product Status
  - 11.3.3 Clinical Trials
  - 11.3.4 Product Milestone
  - 11.3.5 Product Patent Details
- 11.4 BioFoam
  - 11.4.1 Product Description
  - 11.4.2 Product Status
  - 11.4.3 Product Milestone
  - 11.4.4 Product Patent Details
12 Appendix
- 12.1 Methodology
  - 12.1.1 Coverage
  - 12.1.2 Secondary Research
  - 12.1.3 Primary Research
  - 12.1.4 Expert Panel Validation
- 12.2 Contact Us
- 12.3 About Global Markets Direct
- 12.4 Disclaimer
1 List of Tables
- Table 1: CryoLife, Inc.,Key Facts
- Table 2: CryoLife, Inc., Key Employees,
- Table 3: CryoLife, Inc. Pipeline Products by Equipment Type
- Table 4: CryoLife, Inc. Pipeline Products By Development Stage
- Table 5: CryoLife, Inc. Pipeline Products By Therapy Area
- Table 6: CryoLife, Inc. Pipeline Products By Clinical Trials
- Table 7: CryoLife, Inc. Pipeline Products By News Summaries
- 1.2 List of Figures
- Figure 1: CryoLife, Inc. Pipeline Products By Equipment Type
- Figure 2: CryoLife, Inc. Pipeline Products By Equipment Type
- Figure 3: CryoLife, Inc. Pipeline Products By Development Stage
- Figure 4: CryoLife, Inc. Pipeline Products By News Summary
- Figure 5: Global Markets Direct Methodology